Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)

Summary

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) is a medical facility located in Basking Ridge, New Jersey. This center is recognized for care of Leukemia, Breast Cancer, Acute Myelogenous Leukemia, Acute T-Cell Leukemia, Lymphoma and other specialties. Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) is involved with conducting 6 clinical trials across 52 conditions. There are 3 research doctors associated with this hospital, such as Eytan Stein, MD, Alina K Markova, MD, PhD, and Paul Romeser, MD.

Top PIs

Clinical Trials running at Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)

Leukemia

Lymphoma

Breast Cancer

T-Cell Lymphoma

Skin Lymphomas

Acute Myelogenous Leukemia

Lung Cancer

Non-Small Cell Lung Cancer

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Azacitidine + Venetoclax

for Acute Myeloid Leukemia

The purpose of this study is to find out if azacitidine and venetoclax are an effective treatment approach to get rid of or lower measurable residual disease (MRD) in people with acute myeloid leukemia (AML) who have received standard chemotherapy and are planning to have an allogeneic hematopoietic stem cell transplant (HSCT). Allogeneic HSCT, sometimes called a bone marrow transplant, involves receiving healthy blood-forming cells (stem cells) from a donor in order to replace the patient's immune system and lower the chances of the disease returning (relapse).

Recruiting

1 award

Phase 2

7 criteria

Revumenib + Mezigdomide

for Acute Leukemia

The purpose of this study is to find out whether the combination of mezigdomide and revumenib is a safe treatment for people with relapsed or refractory KMT2A-r, NUP98-r, and NPM1-m acute leukemias.

Recruiting

1 award

Phase 1 & 2

5 criteria

Registry

for T-Cell Lymphoma

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Recruiting

1 award

N/A

10 criteria